In support of that view, a protein farnesyltransferase inhibitor (FTI) improves nuclear shape in progerin-expressing cells and ameliorates disease in knock-in and transgenic models of HGPS [11–13, 16, 28–30]. Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.